These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6372866)

  • 1. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
    Kubota M; Carrera CJ; Wasson DB; Carson DA
    Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased level of ribonucleotide reductase in deoxyadenosine resistant adenosine deaminase deficient human histiocytic lymphoma cells.
    Dahbo Y; Carson D; Eriksson S
    Adv Exp Med Biol; 1986; 195 Pt B():231-4. PubMed ID: 3532701
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
    Kubota M; Kamatani N; Daddona PE; Carson DA
    Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of adenine nucleoside excretion and incorporation in adenosine deaminase deficient human lymphoma cells.
    Iizasa T; Kubota M; Carson DA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):514-20. PubMed ID: 6428410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity.
    Chan TS
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
    Lin AL; Elford HL
    J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
    Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
    Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine- and deoxyadenosine-mediated altered pyrimidine metabolism in human adeosine deaminase-deficient lymphoblasts.
    Parker NF; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1982 May; 99(5):731-9. PubMed ID: 6175708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of S49 mouse lymphoma cell mutants deficient in adenosine deaminase.
    Chan TS; Huang C; Sato T
    Somat Cell Mol Genet; 1989 Sep; 15(5):411-20. PubMed ID: 2789437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
    Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
    J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
    Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
    J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Nodzenski E
    Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.